POPULATION PHARMACOKINETICS OF NIVOLUMAB IN JAPANESE PATIENTS WITH NON-SMALL CELL LUNG CANCER.

被引：0
|
作者：
Tohi, M. [1 ]
Mizuno, T. [2 ,3 ]
Irie, K. [1 ,4 ]
Okuyoshi, H. [1 ]
Hirabatake, M. [1 ]
Ikesue, H. [1 ]
Muroi, N. [1 ]
Eto, M. [1 ]
Tomii, K. [1 ]
Hashida, T. [1 ]
Fukushima, S. [4 ]
机构：
[1] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[3] Univ Cincinnati Coll, Cincinnati, OH USA
[4] Kobe Gakuin Univ, Kobe, Hyogo, Japan
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-069
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [21] A retrospective analysis of non-small cell lung cancer patients treated with nivolumab
    Akagi, Kazumasa
    Honda, Noritaka
    Umeyama, Yasuhiro
    Ogawara, Daiki
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Kitazaki, Takeshi
    Nakatomi, Katsumi
    Fukuda, Minoru
    Mukae, Hiroshi
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [23] IMPACT OF DEXAMETHASONE CO-ADMINISTRATION ON LORLATINIB PHARMACOKINETICS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER.
    Reilly, B.
    Pithavala, Y.
    Chen, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S41 - S41
  • [24] The effect of nivolumab treatment for central nervous system metastases in non-small cell lung cancer.
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Takashi
    Ohashi, Kadoaki
    Ichihara, Eiki
    Sato, Akiko
    Hotta, Katsuyuki
    Tabata, Masahiro
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Gut microbiota and clinical outcomes treated with nivolumab in Chinese non-small cell lung cancer.
    Lu, Shun
    Jing, Yueping
    Xia, Liliang
    Li, Ziming
    Yao, Chengcheng
    Wang, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Nivolumab, a new hope in non-small cell lung cancer
    Flippot, Ronan
    Fallet, Vincent
    Besse, Benjamin
    Massard, Christophe
    Wislez, Marie
    Vignot, Stephane
    BULLETIN DU CANCER, 2015, 102 (12) : 1046 - 1052
  • [27] Nivolumab in a patient with HIV and non-small cell lung cancer
    Hentrich, M.
    Schipek-Voigt, K.
    Jaeger, H.
    Schulz, S.
    Schmid, P.
    Stoetzer, O.
    Bojko, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 232 - 232
  • [28] Nivolumab plus chemotherapy for non-small cell lung cancer
    Lichert, Frank
    PNEUMOLOGIE, 2024, 78 (02): : 81 - 81
  • [29] Combination of nivolumab with radiotherapy for non-small cell lung cancer
    Cihan, Y. B.
    ARCHIVES OF HELLENIC MEDICINE, 2022, 39 (06): : 857 - 858
  • [30] Circadian function of patients with advanced non-small cell lung cancer.
    Levin, RD
    Grutsch, JF
    Hrushesky, WJM
    Quiton, J
    Quinn, K
    Daehler, M
    Lis, CG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 693S - 693S
12345